{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:06:30Z","timestamp":1787069190337,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.rpth.2024.102565","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T12:45:42Z","timestamp":1725626742000},"page":"102565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study"],"prefix":"10.1016","volume":"8","author":[{"given":"Christian Herbert","family":"Burgmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich J.","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin","family":"Trautmann-Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pfrepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kn\u00f6bl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Greil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Miesbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Holstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"M\u00f6hnle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"H\u00f6pting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Dobbelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Klamroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3600-8536","authenticated-orcid":false,"given":"Andreas","family":"Tiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102565_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2024.102565_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/10245332.2017.1319115","article-title":"Acquired hemophilia A: a review of recent data and new therapeutic options","volume":"22","author":"Franchini","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.rpth.2024.102565_bib3","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102565_bib4","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1111\/hae.14149","article-title":"The rising incidence of acquired haemophilia A in Germany","volume":"27","author":"Tiede","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102565_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"Knoebl","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102565_bib6","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2014-07-587089","article-title":"Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01\/2010 study","volume":"125","author":"Tiede","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102565_bib7","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/bloodadvances.2021004626","article-title":"Management of acquired hemophilia A: results from the Spanish registry","volume":"5","author":"Mingot-Castellano","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102565_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajh.26009","article-title":"Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study","volume":"96","author":"Schep","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2024.102565_bib9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/hae.12138","article-title":"Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hemophilie Acquise) registry","volume":"19","author":"Borg","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102565_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/MBC.0000000000000582","article-title":"Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry","volume":"27","author":"Kessler","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2024.102565_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/hae.13033","article-title":"Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data","volume":"23","author":"Amano","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102565_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/hae.13685","article-title":"Relapse pattern and long-term outcomes in subjects with acquired haemophilia A","volume":"25","author":"Mizrahi","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102565_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/bjh.16128","article-title":"Outcome of CARE: a 6-year national registry of acquired haemophilia A in China","volume":"187","author":"Sun","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102565_bib14","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"Tiede","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102565_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood-2012-02-409185","article-title":"Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"120","author":"Collins","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102565_bib16","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s00277-020-04150-y","article-title":"Reduced-intensity, risk factor-stratified immunosuppression for acquired hemophilia A: single-center observational study","volume":"99","author":"Dobbelstein","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rpth.2024.102565_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/jth.15208","article-title":"Should emicizumab be used in patients with acquired hemophilia A?","volume":"19","author":"Tiede","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102565_bib18","first-page":"549","article-title":"Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding","volume":"21","author":"Pasca","year":"2023","journal-title":"Blood Transfus"},{"key":"10.1016\/j.rpth.2024.102565_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood-2018-07-820712","article-title":"New therapies using nonfactor products for patients with hemophilia and inhibitors","volume":"133","author":"Nogami","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102565_bib20","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1056\/NEJMoa1511769","article-title":"Factor VIII-mimetic function of humanized bispecific antibody in hemophilia A","volume":"374","author":"Shima","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102565_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000497287","article-title":"Emicizumab in the treatment of acquired haemophilia: a case report","volume":"46","author":"M\u00f6hnle","year":"2019","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.rpth.2024.102565_bib22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/rth2.12201","article-title":"Successful use of emicizumab in a patient with refractory acquired hemophilia A and acute coronary syndrome requiring percutaneous coronary intervention","volume":"3","author":"Dane","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102565_bib23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.12659\/AJCR.916783","article-title":"Emicizumab use in treatment of acquired hemophilia A: a case report","volume":"20","author":"Al-Banaa","year":"2019","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.rpth.2024.102565_bib24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.2020006315","article-title":"Emicizumab for the treatment of acquired hemophilia A","volume":"137","author":"Knoebl","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102565_bib25","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/hae.14809","article-title":"Emicizumab for acquired haemophilia A: a case series","volume":"29","author":"Engelen","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102565_bib26","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jtha.2022.10.004","article-title":"A\u00a0prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A","volume":"21","author":"Shima","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102565_bib27","doi-asserted-by":"crossref","first-page":"e913","DOI":"10.1016\/S2352-3026(23)00280-6","article-title":"Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study","volume":"10","author":"Tiede","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2024.102565_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2024.06.010","article-title":"Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A","author":"Hart","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102565_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.rpth.2024.102565_bib30","article-title":"Emicizumab for the treatment of acquired hemophilia A: consensus recommendations from the GTH-AHA working group","author":"Pfrepper","year":"2023","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.rpth.2024.102565_bib31","first-page":"279","article-title":"Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01\/2010 study","volume":"136","author":"Holstein","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102565_bib32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJM199303043280907","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions","volume":"328","author":"Ware","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102565_bib33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1126\/science.7352265","article-title":"Red blood cells: their dual role in thrombus formation","volume":"207","author":"Turitto","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.rpth.2024.102565_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tmrv.2021.06.001","article-title":"Anemia-induced bleeding in patients with platelet disorders","volume":"35","author":"Thakar","year":"2021","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.rpth.2024.102565_bib35","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/jog.14834","article-title":"Prenatal anemia and postpartum hemorrhage risk: a systematic review and meta-analysis","volume":"47","author":"Omotayo","year":"2021","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.rpth.2024.102565_bib36","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1046\/j.1537-2995.2001.41080977.x","article-title":"Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss","volume":"41","author":"Valeri","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.rpth.2024.102565_bib37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12630-010-9329-x","article-title":"Reassessing the risk of hemodilutional anemia: some new pieces to an old puzzle","volume":"57","author":"Tsui","year":"2010","journal-title":"Can J Anaesth"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924002607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924002607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T19:22:32Z","timestamp":1732216952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924002607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2475037924002607"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102565","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102565"}}